ITPD20050168A1 - Formulazioni di acido lipoico ed acido ialuronico e o suoi derivati e loro impiego in campo farmaceutico e cosmetico - Google Patents

Formulazioni di acido lipoico ed acido ialuronico e o suoi derivati e loro impiego in campo farmaceutico e cosmetico

Info

Publication number
ITPD20050168A1
ITPD20050168A1 IT000168A ITPD20050168A ITPD20050168A1 IT PD20050168 A1 ITPD20050168 A1 IT PD20050168A1 IT 000168 A IT000168 A IT 000168A IT PD20050168 A ITPD20050168 A IT PD20050168A IT PD20050168 A1 ITPD20050168 A1 IT PD20050168A1
Authority
IT
Italy
Prior art keywords
formulations
pharmaceutical
derivatives
acid
cosmetic field
Prior art date
Application number
IT000168A
Other languages
English (en)
Inventor
Davide Bellini
Doriana Senigaglia
Carlo Soranzo
Original Assignee
Fidia Advanced Biopolymers Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Advanced Biopolymers Srl filed Critical Fidia Advanced Biopolymers Srl
Priority to IT000168A priority Critical patent/ITPD20050168A1/it
Priority to US11/921,247 priority patent/US8349355B2/en
Priority to EP06743042A priority patent/EP1890692B1/en
Priority to DE602006007995T priority patent/DE602006007995D1/de
Priority to ES06743042T priority patent/ES2328399T3/es
Priority to PL06743042T priority patent/PL1890692T3/pl
Priority to DK06743042T priority patent/DK1890692T3/da
Priority to PCT/EP2006/004914 priority patent/WO2006128618A1/en
Priority to PT06743042T priority patent/PT1890692E/pt
Priority to CA2610305A priority patent/CA2610305C/en
Priority to SI200630403T priority patent/SI1890692T1/sl
Publication of ITPD20050168A1 publication Critical patent/ITPD20050168A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/21—Acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IT000168A 2005-06-01 2005-06-01 Formulazioni di acido lipoico ed acido ialuronico e o suoi derivati e loro impiego in campo farmaceutico e cosmetico ITPD20050168A1 (it)

Priority Applications (11)

Application Number Priority Date Filing Date Title
IT000168A ITPD20050168A1 (it) 2005-06-01 2005-06-01 Formulazioni di acido lipoico ed acido ialuronico e o suoi derivati e loro impiego in campo farmaceutico e cosmetico
US11/921,247 US8349355B2 (en) 2005-06-01 2006-05-24 Formulations of lipoic acid and hyaluroinc acid and/or the derivatives thereof in the pharmaceutical and cosmetic fields
EP06743042A EP1890692B1 (en) 2005-06-01 2006-05-24 Formulations of lipoic acid and the benzyl ester of hyaluronic acid in the pharmaceutical and cosmetic fields
DE602006007995T DE602006007995D1 (de) 2005-06-01 2006-05-24 Formulierungen von liponsäure und hyaluronsäurebeneichen
ES06743042T ES2328399T3 (es) 2005-06-01 2006-05-24 Formulaciones de acido lipoico y el ester bencilico de acido hialuronico en los campos farmaceutico y cosmetico.
PL06743042T PL1890692T3 (pl) 2005-06-01 2006-05-24 Kompozycje kwasu liponowego i estru benzylowego kwasu hialuronowego w dziedzinie farmacji i kosmetyce
DK06743042T DK1890692T3 (da) 2005-06-01 2006-05-24 Formuleringer af liponsyre og benzylesteren fra hyaluronsyre indenfor det farmaceutiske og kosmetiske område
PCT/EP2006/004914 WO2006128618A1 (en) 2005-06-01 2006-05-24 Formulations of lipoic acid and hyaluronic acid and/or the derivatives thereof in the pharmaceutical and cosmetic fields
PT06743042T PT1890692E (pt) 2005-06-01 2006-05-24 Formulações de ácido lipóico e o éster benzílico de ácido hialurónico nos campos farmacêutico e cosmético
CA2610305A CA2610305C (en) 2005-06-01 2006-05-24 Formulations of lipoic acid and hyaluronic acid and/or the derivatives thereof in the pharmaceutical and cosmetic fields
SI200630403T SI1890692T1 (sl) 2005-06-01 2006-05-24 Formulacije lipojske kisline in benzil estra hialuronske kisline na farmacevtskih in kozmetiäśnih podroäśjih

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000168A ITPD20050168A1 (it) 2005-06-01 2005-06-01 Formulazioni di acido lipoico ed acido ialuronico e o suoi derivati e loro impiego in campo farmaceutico e cosmetico

Publications (1)

Publication Number Publication Date
ITPD20050168A1 true ITPD20050168A1 (it) 2006-12-02

Family

ID=36950241

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000168A ITPD20050168A1 (it) 2005-06-01 2005-06-01 Formulazioni di acido lipoico ed acido ialuronico e o suoi derivati e loro impiego in campo farmaceutico e cosmetico

Country Status (11)

Country Link
US (1) US8349355B2 (it)
EP (1) EP1890692B1 (it)
CA (1) CA2610305C (it)
DE (1) DE602006007995D1 (it)
DK (1) DK1890692T3 (it)
ES (1) ES2328399T3 (it)
IT (1) ITPD20050168A1 (it)
PL (1) PL1890692T3 (it)
PT (1) PT1890692E (it)
SI (1) SI1890692T1 (it)
WO (1) WO2006128618A1 (it)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20072416A1 (it) * 2007-12-21 2009-06-22 Sigea Srl Derivati polisaccaridici dell'acido lipoico, loro preparazione ed uso come dermocosmetici e presidi medicali
IT1397246B1 (it) * 2009-05-14 2013-01-04 Fidia Farmaceutici Nuovi medicamenti ad uso topico a base di acido ialuronico solfatato come agente attivante o inibente l'attivita' citochinica
IT1397247B1 (it) 2009-05-14 2013-01-04 Fidia Farmaceutici Nuovi agenti regolatori dell'attivita' citochinica
JP5823986B2 (ja) * 2010-02-23 2015-11-25 セバナ メディカル リミテッド 脂肪移植物の生存を増大させるための方法及び組成物
IT1403886B1 (it) * 2010-12-15 2013-11-08 Sigea Srl Uso di esteri lipoati di glicosamminoglicani in campo tricologico
US9765182B2 (en) * 2013-09-20 2017-09-19 The United States Of America, As Represented By The Secretary Of Agriculture Elastomer derived from epoxidized vegetable oil
CA2985013C (fr) 2015-05-21 2024-04-16 Ophtalmis Monaco Association d'acide lipoique et de taurine en tant qu'agent osmoprotecteur
PL3297626T3 (pl) * 2015-05-21 2021-12-13 Ophtalmis Kompozycja oftalmiczna zawierająca kwas liponowy i kwas hialuronowy
CN116637226A (zh) * 2022-02-15 2023-08-25 四川大学 一种复合水溶胶及其制备方法与应用
US12152174B2 (en) 2023-04-13 2024-11-26 The Regents Of The University Of California Adjustably stable adhesive compositions for medical and non-medical uses, and recycling
US12269925B1 (en) 2024-08-13 2025-04-08 The Regents Of The University Of California Fast curing, biocompatible and biodegradable adhesives and sealants

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0382066A3 (de) * 1989-02-09 1992-01-08 ASTA Medica Aktiengesellschaft Verwendung von Dihydroliponsäure als Analgetikum, Antiphlogistikum und/oder Zytoprotektivum
IT1254704B (it) * 1991-12-18 1995-10-09 Mini Ricerca Scient Tecnolog Tessuto non tessuto essenzialmente costituito da derivati dell'acido ialuronico
IT1264530B (it) * 1992-07-31 1996-10-02 Crinos Industria Farmaco Impiego dei polisaccaridi nelle neuropatie atrofico degenerative
US5709868A (en) * 1995-09-20 1998-01-20 Perricone; Nicholas V. Lipoic acid in topical compositions
US5785959A (en) * 1996-08-16 1998-07-28 Revlon Consumer Products Corporation Nail strengthening compositions and a method for strengthening nails
EP0855396A1 (en) 1997-01-22 1998-07-29 ASTA Medica Aktiengesellschaft Thioctic acid metabolites and methods of use thereof
US5965618A (en) * 1997-11-17 1999-10-12 Perricone; Nicholas V. Treatment of scar tissue using lipoic acid
IT1306679B1 (it) 1999-06-29 2001-10-02 Fidia Advanced Biopolymers Srl Uso dei derivati dell'acido ialuronico per la preparazione dicomposizoni farmaceutiche e biomateriali per la prevenzione della
JP2001212170A (ja) 2000-02-04 2001-08-07 Toyobo Co Ltd 創傷被覆材
FR2820635B1 (fr) 2001-02-09 2005-01-21 Genevrier Lab Procede de preparation d'une creme a base d'acide hyaluronique
US20040265268A1 (en) * 2001-08-18 2004-12-30 Deepak Jain Compositions and methods for skin rejuvenation and repair
US20040105873A1 (en) * 2002-11-29 2004-06-03 Gupta Shyam K. Topical formulation including stabilized water-soluble and oil-soluble compositions
DE10258239A1 (de) 2002-12-13 2004-06-24 Degussa Ag Formulierung enthaltend alpha-Liponsäure(-Derivate) als alleinigen Wirkstoff bei nichtchronischen alkoholinduzierten Intoxikationen
US20040191330A1 (en) * 2003-03-31 2004-09-30 Keefe Candace R. Daily skin care regimen
US20040262368A1 (en) * 2003-06-26 2004-12-30 Haw Tan Tzyy Ball grid array solder joint reliability

Also Published As

Publication number Publication date
DK1890692T3 (da) 2009-11-16
DE602006007995D1 (de) 2009-09-03
EP1890692A1 (en) 2008-02-27
CA2610305C (en) 2014-05-06
EP1890692B1 (en) 2009-07-22
PT1890692E (pt) 2009-09-10
US20090304758A1 (en) 2009-12-10
US8349355B2 (en) 2013-01-08
PL1890692T3 (pl) 2009-12-31
ES2328399T3 (es) 2009-11-12
SI1890692T1 (sl) 2009-12-31
WO2006128618A1 (en) 2006-12-07
CA2610305A1 (en) 2006-12-07

Similar Documents

Publication Publication Date Title
ITMI20072416A1 (it) Derivati polisaccaridici dell'acido lipoico, loro preparazione ed uso come dermocosmetici e presidi medicali
BRPI1011876A2 (pt) "composição farmacêutica estável e métodos de uso da mesma"
ITPD20050242A1 (it) Bioconiugati antitumorali dell'acido ialuronico o dei suoi derivati, ottenibili per coniugazione chimica diretta o indiretta, e loro impiego in campo farmaceutico
SMT201500224B (it) Derivati purinici per l'uso nel trattamento di malattie allergiche, infiammatorie e infettive
ITMI20061672A1 (it) Formulazioni di acido acetilsalicilico o suoi derivati in capsule molli,esibenti elevata stabilita'
CR10229A (es) Derivados de 1,2,4,5,-tetrahidro-3h-benzazepinas, su procedimiento de preparación y las composiciones farmacéuticas que las contienen
IL201176A (en) 4-amino-1-h-pyrazolo [3,4- d] pyrimidine-3-ram-phenyl, a pharmaceutical containing them and their use in the preparation of a drug
ATE337793T1 (de) Dispergierbare pharmazeutische zusammensetzung eines entzündungshemmers
BRPI0809667A2 (pt) Composto, medicamento e composição farmacêutica que o contém e uso do composto
PT2413913T (pt) Formulações farmacêuticas que compreendem derivados de nitrocatecol e métodos para os preparar
BRPI0718129A2 (pt) Método para o tratamento de partículas pigmentares e composições farmacêuticas para o cuidado pessoal compreendendo as referidas partículas pigmentare
IT1392249B1 (it) Derivati di [(3-idrossi-4-piron-2-il)metil]-amina e loro uso come farmaci anti-neoplastici
IT1362675B (it) N-idrossiammidi -sostituiti con gruppi triciclici come inibitori dell'istone deacelitasi,loro preparazione ed impiego in formulazioni farmaceutiche
SI1890692T1 (sl) Formulacije lipojske kisline in benzil estra hialuronske kisline na farmacevtskih in kozmetiäśnih podroäśjih
SMT201300080B (it) Derivati di carbammati di alchiltiazoli, loro preparazione e loro utilizzo come inibitori dell'enzima faah
BRPI0920355A2 (pt) composições farmacêuticas tópicas estáveis de ozenoxacina e uso de ozenoxacina
EP2348018A4 (en) HETEROCYCLIC BIARYL DERIVATIVE AND PDE INHIBITOR CONTAINING ACTIVE SUBSTANCE
IL194880A (en) Aminazole amine derivatives, their use in the treatment of diseases and pharmaceuticals containing them
DK2448940T3 (da) Derivater af 6,7,8,9 tetrahydro-pyrimido{1,2-a}pyrimidin-4-on, fremstilling og farmaceutisk anvendelse heraf
IT1398773B1 (it) Sequenze oligonucleotidiche inibitrici dell'espressione della chimera ciclina d1/trop2 e loro uso in campo medico.
ITRM20070038A1 (it) Forme solubili di complessi di inclusione di inibitori dell istone deacetilasi e ciclodestrine loro processi di preparazione e impieghi in campo farmaceutico
BR112012016736A2 (pt) composição , formulação farmacêutica e uso da composição"
EP2196463A4 (en) PREPARATION OF 5,6-DIMETHYLXANTHONE-4-ACETIC ACID, DERIVATIVES DERIVATED THEREOF AND PHARMACEUTICAL FORMULATIONS THEREOF
FR2920774B1 (fr) Nouveaux derives de n-phenul acatamide, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contentant
NO20084860L (no) Stabile farmasøytiske preparater av 2-aza-bisyklo-[3,3,0]-oktan-3-karboksylsyrederivater